Replies to post #12951 on Momenta Pharmaceuticals, Inc. (MNTA)

[DewDiligence]

The patent in question has been restored for the time being. However, this patent was never in the FDA’s Orange Book, so under Hatch-Waxman rules it ought not to affect FDA decision-making at all. Whether this patent does affect the FDA in practice, who knows?